drugset

drugset / Trial / NCT00566865

Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil

NCT00566865 ↗

Phase 1 Completed 14 enrolled Elixir Pharmaceuticals

RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary objective of this study is to determine the extent of effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of mitiglinide.

Timeline

Start: 2007-11
Primary completion: 2007-12
Completion: 2007-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gemfibrozil	Small molecule	600 mg	—

Indications